• Twitter
  • LinkedIn
  • Contact
  • MAPS Community Portal Login
Medical Affairs Professional Society
  • Home
  • About
    • Mission, Vision & Value
    • Diversity, Equity & Inclusion
    • What is MA?
    • MAPS Leadership
    • Focus Area Working Groups
    • Partner Circle
    • Media/Sponsorship
    • Bylaws
    • Contact
    • Annual Report 2020
  • Membership
    • Membership Benefits
    • Industry Partnership Program
  • Chapters
  • Mentorship
  • Career Center
  • Events
  • Content HUB
  • Contact
  • Menu Menu
CONTENT TYPE, Elevate Magazine, CAPABILITIES & COMPETENCIES, Open Access, Content HUB Featured, FOCUS AREA, ACCESS, Content Hub, Leadership & Management, Strategic Vision, Medical Strategy & Launch Excellence

MAPS Board Chair, Charlotte Kremer: Why The Strategic Rise of Medical Affairs Is Central to Pharma’s Future Success

Charlotte Op Ed Featured

It’s no secret that major forces have pushed the pharmaceutical industry to think differently about how it operates and how it can deliver greater value to society. The good news is that we’re seeing more connected, more agile and more outcomes-focused organizations arise from the disruption.

R&D teams have increasingly broken free from traditional scientific silos through increased internal collaboration and external partnerships with biotech and academia. They have embraced transformative science and technological advances and we are starting to see a new generation of medicines forged by our enhanced ability to capture, interpret and apply data.

Our engagement models have also adapted to changing stakeholder needs. More specialty products with more complex data mean that our clinical and access stakeholders are demanding deeper scientific exchanges to understand the patient impact and value to society.

 

What’s changed in Medical Affairs?

Like many pharma companies, the role of Medical Affairs at Astellas has transformed in recent years, from a support function to a strategic organization to internal and external stakeholders.

Today, Medical Affairs is comprised of the most important and valued capabilities in the business, playing the role of key connector between internal pharma and external stakeholders.

We are driving scientific exchange and evidence generation with an ever-expanding external stakeholder community of healthcare professionals, scientific experts, health authority bodies, payers and patients.

Our role is not just limited to knowing what these stakeholders want and need. We’re fulfilling information needs through data-generation (clinical trials and real-world data analyses), data sharing through publications, medical information and scientific exchange, pinpointing the investments and activities that will drive the biggest impact for each of these groups. The result, ensuring the safety, efficacy, value and real-world utilization of our therapies are fully understood.

As Medical Affairs integrates its wealth of external insights into a consolidated and aligned strategy to guide its own global activities, it also needs to align with Commercial and R&D colleagues. Through governance and operational excellence, Medical Affairs ensures information needs and data are shared across organizations, as and when needed, to enhance the effectiveness and impact of all respective groups.

 

Leading value creation in the future

As our operating environment has changed, Medical Affairs has become a more business-savvy, scientifically influential, connected and agile function. While we’re making great progress, companies like Astellas know that the disruption won’t stop.

New challenges lie ahead, such as our ability to address wider societal issues and to create value for a variety of stakeholders that is wider than ever before. Another key challenge for us will be the use of artificial intelligence to generate data from combined big data sources, such as clinical health records, real-world data and the variety of ‘omics’ data sets. This information will need to be delivered in an increasingly digitally-savvy way, for example via interactive medical information websites and other digital channels.

We also know that downward pricing pressures are unlikely to go away. We will need to demonstrate how innovations create value to a wider variety of stakeholders than ever before. So, every commercial decision will have greater consequences.

With this mind, I believe that Medical Affairs professionals must continue to build on the range of capabilities that enable them to act as orchestrators of company strategy with R&D and Commercial functions. Central to this is effective leadership. Medical Affairs leaders need to be ready to interact with the C-Suite and inform corporate strategies because it is helping companies to make smarter decisions and focus performance measures on patient-centric outcomes. And that’s value creation that makes a real difference.

 

Charlotte KremerCharlotte Kremer, M.D.

EVP, Head of Medical Affairs,

Astellas Pharma Inc.

October 13, 2020/by Guest Author
Tags: Medical Affairs Professional Society, charlotte kremer
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Reddit
  • Share by Mail
https://medicalaffairs.org/wp-content/uploads/2020/10/Charlotte-Op-Ed-Featured.png 321 845 Guest Author https://medicalaffairs.org/wp-content/uploads/2021/03/imgpsh_mobile_save-300x97.jpg Guest Author2020-10-13 10:31:462020-10-22 11:59:52MAPS Board Chair, Charlotte Kremer: Why The Strategic Rise of Medical Affairs Is Central to Pharma’s Future Success
You might also like
MONOCL Podcast 1 Featured PODCAST: Expert Engagement — Driving the Strategic Impact of Medical Affairs
Isma.Amgen .Survey Amgen Europe Medical Affairs Survey: Post-COVID Healthcare Provider Preferences for MSL Interactions

Related Posts


April 15, 2021

The Value of Medical Information to Internal Stakeholders

MedInfo Teams contribute to the business with clinical expertise, extensive knowledge of the company products and medical literature, insights of customer needs, and a strong understanding of the business.

April 14, 2021

From Support Function to a Strategic Pillar, Medical Affairs is Defying Convention by Breaking Down Silos  

In this dynamic and conversational webinar, we will review how adaptive connected technology and processes support our mandate to deliver integrated evidence that articulates clear clinical and economic value to improve patient experience and outcomes.

April 12, 2021

Insights: Social Listening for Insights

This MAPS podcast introduces listeners to social listening to gather insights and discusses implementation, value and technologies.

April 7, 2021

The U.S. National Health Council’s Programs: An Introduction and How Medical Affairs Professionals Can Become Involved

This session describes the National Health Council​ and opportunities for Medical Affairs professionals to get involved.

Search

Follow MAPS on LinkedIn:

MAPS LinkedIn
Popular
  • Pandemic MedTech 1 FeaturedA Pandemic Silver Lining for the MedTech Industry? Part...November 18, 2020 - 6:06 pm
  • Murali Gopal FeaturedWhy Good Science is Good Business: A Conversation with Murali...October 15, 2020 - 12:05 pm
  • Value of Medical Information FeaturedThe Value of Medical Information to Internal Stakeholde...April 15, 2021 - 12:03 pm
  • MAPS 2022 Global Annual Meeting New Orleans Medical AffairsMAPS Global Annual Meeting Returns March 2022January 28, 2017 - 2:11 pm
  • 9The Power of PurposeJanuary 15, 2018 - 10:50 am
  • Agility Medical Affairs StrategyBuilding Agility into Medical Affairs Strategy: Global-Regional-Local...March 1, 2018 - 10:50 am

CLICK HERE to sign up to receive updates. You can customize your communication preferences at any time.

Quick Links

  • Home
  • About
  • Membership
  • Med Affairs Calendar
  • Contact Us

Useful Links

  • Leadership
  • Conferences
  • Member Login

© 2021 Medical Affairs Professional Society.All Rights Reserved.

Latest News &
Updates

MAPS COVID-19 Town Hall: April 21

Read More

MAPS Appoints First Chair of New Exec Program Committee

Read More

MAPS Announces Board Expansion

Read More

View All

MAPS News & Announcements

CLICK HERE to sign up to receive updates. You can customize your communication preferences at any time.

© 2021 Medical Affairs Professional Society.All Rights Reserved.

Legal & Privacy Policies

PODCAST: Expert Engagement — Driving the Strategic Impact of Medical ... MONOCL Podcast 1 Featured Murali Gopal Featured Why Good Science is Good Business: A Conversation with Murali Gopal, MD
Scroll to top